1,032 reports of this reaction
4.2% of all ESKETAMINE HYDROCHLORIDE reports
#4 most reported adverse reaction
DRUG INEFFECTIVE is the #4 most commonly reported adverse reaction for ESKETAMINE HYDROCHLORIDE, manufactured by Janssen Pharmaceuticals Inc.. There are 1,032 FDA adverse event reports linking ESKETAMINE HYDROCHLORIDE to DRUG INEFFECTIVE. This represents approximately 4.2% of all 24,470 adverse event reports for this drug.
Patients taking ESKETAMINE HYDROCHLORIDE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among ESKETAMINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for ESKETAMINE HYDROCHLORIDE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 1,032 FDA reports for ESKETAMINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 4.2% of all adverse event reports for ESKETAMINE HYDROCHLORIDE, making it a notable side effect.
If you experience drug ineffective while taking ESKETAMINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.